TGFB1 and idiopathic pulmonary fibrosis: However, our data showing that the inhibition of TGF-β1 signaling might accompany there-emergence of PQ toxicity, probably due to the loss of resistance to anoikis, indicates that caution should be exercised when attempting IPF treatments that involve the modulation of TGF-β1 signaling.